Our Thoughts

Markets closed November strong—S&P 500 at 6,849 and TSX at 31,382—defying negative headlines. The real story? AI growth is accelerating, not hype. Demand for compute power is outpacing supply, creating structural investment opportunities....

Life insurers show strong ROEs and global growth, while P&C names offer defensive stability. AI is transforming underwriting and client engagement, and Asia’s rapid expansion creates new opportunities. Watch to hear Tom's outlook....

Our outlook on the markets from our October 2025 market commentary...

Our latest conversation with Economist Rob Kavcic dives into USMCA tariff negotiations, pro-growth fiscal policies in the upcoming federal budget, the housing market dynamics and Canadian dollar trends amid monetary policy shifts....

October brought drama from Washington to Wall Street – and a thrilling World Series run from the Jays. Our latest market snapshot breaks down the headlines and what they mean for investors....

In this first episode of our MSB Wealth Mini Series with Sarah King, we explore how whole life insurance and critical illness coverage can help families plan ahead and build lasting financial security for their children and grandchildren....

Our outlook on the markets from our September 2025 market commentary...

September saw the Fed and Bank of Canada cut rates—and investors didn’t flinch. The S&P 500 climbed. The TSX surged. Earnings held strong. Is this the top? Not quite. It might just be the foothill before the next climb....

We recently launched a new webinar series and our first session features Jennifer Louth from Franklin Templeton, who explored how innovation is shaping the future....

What’s next for healthcare, pharmaceuticals, and biopharma? We sat down with Evan to explore key themes driving pharma today, breakthroughs in biopharma innovation and policy and pricing headwinds shaping the sector...